Age-related Neuroendocrine, Cognitive, and Behavioral Co-Morbidities Are Promoted by HIV-1 Tat Expression in Male Mice by Qraeya, Alaa et al.
University of Mississippi 
eGrove 
Annual Poster Session 2021 Annual Poster Session 
10-19-2021 
Age-related Neuroendocrine, Cognitive, and Behavioral Co-
Morbidities Are Promoted by HIV-1 Tat Expression in Male Mice 
Alaa Qraeya 
University of Mississippi, anqrarey@go.olemiss.edu 
Fakhri Mahdi 
University of Mississippi 
Marc Kaufman 
Harvard University 
Nicole M. Ashpole 
University of Mississippi 
Jason J. Paris 
University of Mississippi 
Follow this and additional works at: https://egrove.olemiss.edu/pharm_annual_posters_2021 
 Part of the Pharmacy and Pharmaceutical Sciences Commons 
Recommended Citation 
Qraeya, Alaa; Mahdi, Fakhri; Kaufman, Marc; Ashpole, Nicole M.; and Paris, Jason J., "Age-related 
Neuroendocrine, Cognitive, and Behavioral Co-Morbidities Are Promoted by HIV-1 Tat Expression in Male 
Mice" (2021). Annual Poster Session 2021. 5. 
https://egrove.olemiss.edu/pharm_annual_posters_2021/5 
This Book is brought to you for free and open access by the Annual Poster Session at eGrove. It has been accepted 




HIV-1 Tat expression will accelerate or accentuate
age-related comorbidities including, cognitive,
affective, neuromuscular, and neuropathic pain.
Tat protein will impact the neuroendocrine
capacity concurrent with behavioral deficits.
Methods
Advanced Age and Tat Reduced Neuromuscular 
Strength Among Male Mice
Advanced Age or Tat Increased Anxiety-Like 
Behavior Among Male Mice
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Figure1. Circulating (serum; ng/mL) and central (ng/g) steroid hormones among young adult and middle-aged HIV-1 Tat-transgenic male mice [Tat(+)] or their non-Tat-
expressing age-matched counterparts [Tat(-)]. (A) Testosterone (T), (B) estradiol (E2), (C) the E2:T ratio, (D) progesterone, and (E) corticosterone detected in serum. (F)
Hippocampal, (G) midbrain, and (H) frontal cortex allopregnanolone (alloP) detected in grossly-dissected brain regions. * main effect for Tat(+) mice to differ from Tat(-)
controls. † main effect for middle-aged mice to differ from young adults. ^ significant interaction wherein indicated group differs from respective Tat(-) controls. ‡ indicated
group differs from all other groups. § indicated group differs from young adult Tat(-) controls (two-way ANOVA, p < 0.05)
Advanced Age or Tat Reduced Cognitive Performance in Male Mice
A B
Background Advanced Age and Tat Exposure Altered Steroidogenesis in Male Mice
 Combination antiretroviral therapy (cART) has significantly
reduced the incidence of HIV-1 associated dementia and
increased life expectancy among infected patients. However,
~50% of the HIV+ population still suffer from neurological
and psychological symptoms, including increased incidence
of cognitive deficits, anxiety/depression, and neuropathic
pain, collectively called neuroHIV [1,3].
 HIV-1 proteins, such as the trans-activator of transcription
(Tat), are neurotoxic, remain present in the central nervous
system despite combined antiretroviral therapy, and are
thought to contribute to neuroHIV [2-5].
 The U.S. HIV+ population is aging with ~60% over the age of
50 years old. These individuals experience accelerated
aging and characterized by vulnerability to numerous age-
related comorbidities, including endocrine and immune
dysfunction, neurocognitive deficits, vascular and metabolic
disorders [3-6].
 HIV-1 Tat protein, cART, and chronological aging can disrupt
endocrine function, dysregulate the hypothalamic-pituitary-
gonadal axis, and impair steroidogenesis. [4-9].
Animal Housing
HIV-1 Tat transgenic mice were generated in the vivarium at the University of Mississippi (University, MS). HIV-1 Tat1-
86 protein is expressed via a glial fibrillary acidic protein (GFAP)-driven, tetracycline (Tet)-on promoter activated by
doxycycline (30 mg/kg, i.p.). Young adult (6-8 months old; nTat(-) = 9, nTat(+) = 12) or middle-aged (11-13 months old;
nTat(-) = 12, nTat(+) = 10) male mice that expressed Tat (Tat+) and their non-Tat-expressing counterparts (Tat-) were
housed (3-4/cage) in a temperature- and humidity-controlled room on a reversed 12:12 h light/dark cycle (lights off at
20:00 h).
Open Filed (OF)
Mice were placed at the center area of an open field apparatus (40×40×35 cm) and allowed to freely explore for 5
min. Mice were digitally tracked and recorded by ANY-maze software tracking system. A greater proportion of central
entries was used as an index for anti-anxiety-like behavior. Total distance travelled was used as an index for
locomotor activity.
Radial Arm Water Maze (RAWM)
Mice were placed in an 8-arm radial arm water maze with the goal of reaching a hidden platform. During training,
mice performed 6 trials/day with each trial ending when the mouse either reached the hidden platform or after 60 s.
When mice failed to locate the platform, they were gently guided to it and allowed to remain for 15 s. The total
number of errors and greater latency to reach the platform were used as indictor of a hippocampus-dependent
learning and memory deficits.
Thermal Hyperalgesia
A radiant heat source was applied to the middle plantar surface of the hind paw (2.5 ̊C/sec) until paw withdrawal.
Each mouse underwent 4 trials (2: right and 2: left) with a 3 -5 min interval break between trials.
Steroid Extraction/ Enzyme-Linked Immunosorbent Assay (ELISA)
Steroids were extracted from serum via ether-snap freezing. Samples were reconstituted in extraction buffer and
assessed via ELISA for corticosterone, estradiol, and testosterone per manufacturer instructions (Neogen Life
Sciences, Lexington, KY). Plates were read on a CLARIOstar microplate reader (BMG Labtech Inc., Cary,NC) at 650
nm absorbance.
Ultra Performance Liquid Chromatography (UPLC) - Mass Spectrometry (MS)
Brain regions (prefrontal cortex, midbrain, hippocampus) were grossly-dissected. Charcoal-stripped brain tissues
derived from Tat-tg mice were used for calibration and quality control. Steroid extraction as achieved via protein
precipitation with samples homogenized in 100 μl of PBS (pH 7.4). Samples were precipitated with 100 µl of
acetonitrile followed by vortexing for 2 min and centrifugation. Following centrifugation, supernatants were mixed with
50 μl of derivatizing solution and incubated for 1 h. 20 μl of the internal standard solution (1 μg/ml) was added and
vortexed. For analysis, 2 μl of sample was injected onto the UPLC-MS/MS instrument.
Figure 2. (A-B) Spatial memory performance in a radial arm water maze and (C) simple linear regressions for circulating and central steroid hormones among young adult and
middle-aged HIV-1 Tat-transgenic male mice [Tat(+)] or their non-Tat-expressing age-matched counterparts [Tat(-)]. (A) Proportion of mice that exhibited improvement from
day one performance (latency to escape). (B) Total frequency of errors. (C) circulating estradiol and frequency of errors. * main effect for Tat(+) mice to differ from Tat(-) mice.
^ interaction effect wherein indicated group differs from young adult Tat(-) controls. ‡ indicated middle-aged Tat(+) groups differs from middle-aged Tat(-) and young adult
Tat(+) mice. Regression lines (solid) are depicted with 95% confidence intervals (dotted), (repeated measure ANOVA, p < 0.05)
Figure 3: (A-B) Anxiety-like behavior in the open field and (A’-B’) simple linear regressions between circulating and
central steroid hormones among young adult and middle-aged HIV-1 Tat-transgenic male mice [Tat(+)] or their non-
Tat-expressing age-matched counterparts [Tat(-)]. (A) Time (s) spent in the brightly-lit center of an open field. (B)
Numbers of entries made into the center of an open field. Regressions between (A’) circulating corticosterone and
center time, (B’) hippocampal allopregnanolone and center entries.* main effect for Tat genotype wherein Tat(+)
mice to differ from Tat(-) mice. † main effect for middle-aged mice to differ from young adult mice. ^ significant
interaction wherein indicated group differs from young adult Tat(-) controls. Regression lines (solid) are depicted
with 95% confidence intervals (dotted), (two-way ANOVA, p < 0.05)
Thus, HIV-1 Tat promoted cognitive deficits, anxiety–like behavior, and
neuromuscular middle-aged male mice in a manner coincident with their
neuroendocrine aging status. Future studies will determine whether
administration of exogenous steroid hormones to aged Tat-exposed exert
cognitive, affective, and nociceptive benefits.
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Conclusion 
Figure 4: (A) Grip strength, (B) thermal hyperalgesia and (A’ and B’) simple linear regression for circulating and central
steroid hormones among young adult and middle-aged HIV-1 Tat-transgenic male mice [Tat(+)] or their non-Tat-expressing
age-matched counterparts [Tat(-)]. (A) Grip strength threshold forelimbs and hindlimbs together . (B) Paw-withdrawal
latency (s) in a thermal probe test. Simple linear regressions between (A’) circulating corticosterone and forelimbs and
hindlimbs together (B’) hippocampal allopregnanolone and paw-withdrawal latency. * main effect for Tat(+) mice to differ
from Tat(-) mice. † main effect for middle-aged mice to differ from young adults. ^ significant interaction wherein indicated
group differs from young adult Tat(-) controls. Regression lines (solid) are depicted with 95% confidence intervals





6x trials/day for 3d
Hidden platform
F G H
Serum
B B’
^
†
0 0
‡
‡
‡‡
‡
*
*
†
*
*
^
^
^
A A’
B B’ (ng/ml)
(ng/g)
^ ^
‡
‡
^ ^
A A’
^
^ ^
†
^
§
